lutetium lu 177 vipivotide tetraxetan,cabazitaxel
emcure,sanofi,novartis
['therap ']
 presents the #therap 3 year results for #asco22 
Clinical trial program manager - oncology, @TrialsCentre @Sydney_Uni. PhD. She/her.